Brief: AcelRx Pharma Says Received Close-Out Letter From OPDP Indicating FDA Concluded Its Evaluation Of Co's Corrective Actions In Response To Warning Letter
31/03/2022 22:13
March 31 (Reuters) - AcelRx Pharmaceuticals Inc ACRX.O :
* ACELRX PHARMA - RECEIVED CLOSE-OUT LETTER FROM OPDP
INDICATING
FDA CONCLUDED ITS EVALUATION OF CO'S CORRECTIVE ACTIONS IN
RESPONSE TO WARNING LETTER
Further company coverage: ACRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Talphera
See all newsTalphera Inc reports results for the quarter ended June 30 - Earnings Summary
Talphera Inc expected to post a loss of 7 cents a share - Earnings Preview
Talphera Q1 net loss narrows as costs rise on higher development spending
Talphera Q4 net loss widens as operating expenses rise
Brief: Talphera Announces 50% Enrollment Milestone In Ongoing Nephro-Crrt Registrational Trial